TY  - RPRT
TI  - Formulary conversion programs: the need for patient-specific risk assessment.
AU  - Sonal Singh
AU  - Rakesh Shrivastava
AU  - Vijay Das
PY  - 2004
UR  - https://pubmed.ncbi.nlm.nih.gov/15520652/
ID  - 15520652
ER  -